603233 大参林
已收盘 09-24 15:00:00
资讯
新帖
简况
股市必读：大参林新发布《大参林医药集团股份有限公司关于召开2026年半年度业绩说明会的公告》
证券之星 · 09-23
股市必读：大参林新发布《大参林医药集团股份有限公司关于召开2026年半年度业绩说明会的公告》
股市必读：大参林新发布《大参林医药集团股份有限公司2026年第二次临时股东会决议公告》
证券之星 · 09-14
股市必读：大参林新发布《大参林医药集团股份有限公司2026年第二次临时股东会决议公告》
每周股票复盘：大参林（603233）股东会通过员工持股平台参股子公司议案
证券之星 · 09-13
每周股票复盘：大参林（603233）股东会通过员工持股平台参股子公司议案
股市必读：大参林新发布《大参林医药集团股份有限公司2026年第二次临时股东会会议材料》
证券之星 · 09-03
股市必读：大参林新发布《大参林医药集团股份有限公司2026年第二次临时股东会会议材料》
大参林（603233）披露拟通过员工持股平台间接参股安徽及新疆子公司，9月2日股价下跌1.79%
证券之星 · 09-02
大参林（603233）披露拟通过员工持股平台间接参股安徽及新疆子公司，9月2日股价下跌1.79%
每周股票复盘：大参林（603233）2026年中报净利增16.1%
证券之星 · 08-30
每周股票复盘：大参林（603233）2026年中报净利增16.1%
研报掘金丨中邮证券：维持大参林“买入”评级，利润增长亮眼，经营质量持续提升
格隆汇 · 08-28
研报掘金丨中邮证券：维持大参林“买入”评级，利润增长亮眼，经营质量持续提升
中邮证券：给予大参林买入评级
证券之星 · 08-28
中邮证券：给予大参林买入评级
大参林（603233）2026年中报简析：营收净利润同比双双增长，盈利能力上升
证券之星 · 08-26
大参林（603233）2026年中报简析：营收净利润同比双双增长，盈利能力上升
股市必读：大参林中报 - 第二季度单季净利润同比增长22.89%
证券之星 · 08-26
股市必读：大参林中报 - 第二季度单季净利润同比增长22.89%
大参林(603233)6月30日股东户数2.56万户，较上期增加0.84%
证券之星 · 08-25
大参林(603233)6月30日股东户数2.56万户，较上期增加0.84%
8月25日大参林涨6.05%，兴全兴益债券A基金重仓该股
证券之星 · 08-25
8月25日大参林涨6.05%，兴全兴益债券A基金重仓该股
国金证券：给予大参林买入评级
证券之星 · 08-25
国金证券：给予大参林买入评级
图解大参林中报：第二季度单季净利润同比增长22.89%
证券之星 · 08-25
图解大参林中报：第二季度单季净利润同比增长22.89%
大参林（603233）披露2026年半年度报告，8月24日股价下跌1.7%
证券之星 · 08-24
大参林（603233）披露2026年半年度报告，8月24日股价下跌1.7%
大参林较去年高点跌65.59% 中泰证券等在高位喊买入
中金财经 · 08-12
大参林较去年高点跌65.59% 中泰证券等在高位喊买入
A股收评：沪指涨1.02%，超2800股上涨！CRO概念、AI硬件板块爆发
格隆汇 · 08-07
A股收评：沪指涨1.02%，超2800股上涨！CRO概念、AI硬件板块爆发
每周股票复盘：大参林（603233）2025年营收275.02亿元
证券之星 · 07-26
每周股票复盘：大参林（603233）2025年营收275.02亿元
股市必读：新发布《天健会计师事务所（特殊普通合伙）关于大参林医药集团股份有限公司2025年年度报告问询函专项说明》
证券之星 · 07-22
股市必读：新发布《天健会计师事务所（特殊普通合伙）关于大参林医药集团股份有限公司2025年年度报告问询函专项说明》
股市必读：新发布《天健会计师事务所（特殊普通合伙）关于大参林医药集团股份有限公司2025年年度报告问询函专项说明》
证券之星 · 07-21
股市必读：新发布《天健会计师事务所（特殊普通合伙）关于大参林医药集团股份有限公司2025年年度报告问询函专项说明》
加载更多
公司概况
公司名称：
大参林医药集团股份有限公司
所属行业：
零售业
上市日期：
2017-07-31
主营业务：
大参林医药集团股份有限公司的主营业务是中西成药、参茸滋补药材及中药饮片、保健品、医疗器械及其他商品的连锁零售业务。公司的主要产品是中西成药、中参药材、非药品。
发行价格：
24.72
{"stockData":{"symbol":"603233","market":"SH","secType":"STK","nameCN":"大参林","latestPrice":17.55,"timestamp":1790233200000,"preClose":17.97,"halted":0,"volume":7448269,"delay":0,"changeRate":-0.0234,"floatShares":1139000000,"shares":1139000000,"eps":1.1976,"marketStatus":"已收盘","change":-0.42,"latestTime":"09-24 15:00:00","open":18,"high":18.21,"low":17.51,"amount":132000000,"amplitude":0.039,"askPrice":17.55,"askSize":33,"bidPrice":17.54,"bidSize":60,"shortable":0,"etf":0,"ttmEps":1.1976,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1790559000000},"marketStatusCode":5,"adr":0,"adjPreClose":17.97,"symbolType":"stock","openAndCloseTimeList":[[1790213400000,1790220600000],[1790226000000,1790233200000]],"highLimit":19.77,"lowLimit":16.17,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1138854520,"isCdr":false,"pbRate":2.65,"roa":"--","peRate":14.654309,"roe":"11.59%","epsLYR":1.08,"committee":0.813028,"marketValue":19987000000,"turnoverRate":0.0065,"status":1,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2026-09-28。","floatMarketCap":19987000000},"requestUrl":"/m/hq/s/603233","defaultTab":"news","newsList":[{"id":"2669096126","title":"股市必读：大参林新发布《大参林医药集团股份有限公司关于召开2026年半年度业绩说明会的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2669096126","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669096126?lang=zh_cn&edition=full","pubTime":"2026-09-23 01:20","pubTimestamp":1790097624,"startTime":"0","endTime":"0","summary":"公司公告汇总大参林医药集团股份有限公司关于召开2026年半年度业绩说明会的公告大参林医药集团股份有限公司将于2026年9月30日16:00–17:00通过上证路演中心网络互动方式召开2026年半年度业绩说明会，介绍公司半年度经营及财务状况。大参林医药集团股份有限公司关于“大参转债”到期兑付暨摘牌的第二次提示性公告“大参转债”到期日和兑付登记日为2026年10月21日，兑付本息金额为110.00元人民币/张（含税），兑付资金发放日为2026年10月22日。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092300002141.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0114","159938","BK0185","BK0209","603233","09939","BK1161","BK1574","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667638234","title":"股市必读：大参林新发布《大参林医药集团股份有限公司2026年第二次临时股东会决议公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2667638234","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667638234?lang=zh_cn&edition=full","pubTime":"2026-09-14 03:58","pubTimestamp":1789329491,"startTime":"0","endTime":"0","summary":"截至2026年9月11日收盘，大参林报收于17.7元，下跌1.39%，换手率0.69%，成交量7.91万手，成交额1.4亿元。公司公告汇总：大参林于9月11日召开2026年第二次临时股东会，审议通过《关于员工持股平台参股子公司的议案》，同意票占比99.9521%。交易信息汇总资金流向9月11日主力资金净流入137.48万元，占总成交额0.98%；游资资金净流出1751.86万元，占总成交额12.54%；散户资金净流入1614.38万元，占总成交额11.56%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091400001714.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1515","BK0185","603233","BK1161","BK1574","09939","BK0114","BK0209","159938"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667500423","title":"每周股票复盘：大参林（603233）股东会通过员工持股平台参股子公司议案","url":"https://stock-news.laohu8.com/highlight/detail?id=2667500423","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667500423?lang=zh_cn&edition=full","pubTime":"2026-09-13 03:43","pubTimestamp":1789242191,"startTime":"0","endTime":"0","summary":"截至2026年9月11日收盘，大参林报收于17.7元，较上周的18.79元下跌5.8%。本周关注点公司公告汇总：股东大会审议通过《关于员工持股平台参股子公司的议案》，表决同意率达99.9521%公司公告汇总大参林医药集团股份有限公司于2026年9月11日召开2026年第二次临时股东会，会议由董事会召集，董事柯国强主持，采用现场与网络投票方式举行。本次股东大会于2026年9月11日以现场和网络投票方式召开，审议通过了《关于员工持股平台参股子公司的议案》。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091300001372.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0209","BK0114","BK0185","603233"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664845077","title":"股市必读：大参林新发布《大参林医药集团股份有限公司2026年第二次临时股东会会议材料》","url":"https://stock-news.laohu8.com/highlight/detail?id=2664845077","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664845077?lang=zh_cn&edition=full","pubTime":"2026-09-03 02:34","pubTimestamp":1788374054,"startTime":"0","endTime":"0","summary":"截至2026年9月2日收盘，大参林报收于18.08元，下跌1.79%，换手率0.57%，成交量6.51万手，成交额1.19亿元。公司公告汇总大参林医药集团股份有限公司2026年第二次临时股东会会议材料大参林拟通过员工持股平台广州集芸智投资服务合伙企业间接参股安徽大参林药业有限公司和新疆大参林医药连锁有限公司。公司放弃相关优先权利，本次交易不影响合并报表范围及控制权。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090300002211.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1574","BK0209","09939","603233","159938","BK0114","BK0185","BK1515","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664101628","title":"大参林（603233）披露拟通过员工持股平台间接参股安徽及新疆子公司，9月2日股价下跌1.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2664101628","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664101628?lang=zh_cn&edition=full","pubTime":"2026-09-02 22:54","pubTimestamp":1788360852,"startTime":"0","endTime":"0","summary":"截至2026年9月2日收盘，大参林报收于18.08元，较前一交易日下跌1.79%，最新总市值为205.9亿元。近日，大参林医药集团股份有限公司披露《2026年第二次临时股东会会议材料》。公告显示，公司拟通过员工持股平台广州集芸智投资服务合伙企业间接参股安徽大参林药业有限公司和新疆大参林医药连锁有限公司。通过合肥集芸智和乌鲁木齐集芸智两个省级合伙平台分别持有安徽和新疆子公司股权，间接持股比例分别为9.17%和9.28%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090200043333.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603233","BK0185","BK0209","BK0114"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663010971","title":"每周股票复盘：大参林（603233）2026年中报净利增16.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663010971","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663010971?lang=zh_cn&edition=full","pubTime":"2026-08-30 03:00","pubTimestamp":1788030037,"startTime":"0","endTime":"0","summary":"截至2026年8月28日收盘，大参林报收于18.15元，较上周的17.66元上涨2.77%。本周，大参林8月26日盘中最高价报18.68元。大参林当前最新总市值206.7亿元，在医药商业板块市值排名4/32，在两市A股市值排名969/5211。本周关注点来自业绩披露要点：大参林2026年上半年归母净利润9.27亿元，同比上升16.1%。股本股东变化截至2026年6月30日，大参林股东户数为2.56万户，较3月31日增加214.0户，增幅0.84%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083000000973.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0209","603233","BK0185","BK0114"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662068120","title":"研报掘金丨中邮证券：维持大参林“买入”评级，利润增长亮眼，经营质量持续提升","url":"https://stock-news.laohu8.com/highlight/detail?id=2662068120","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662068120?lang=zh_cn&edition=full","pubTime":"2026-08-28 16:56","pubTimestamp":1787907408,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["603233","161027","BK0185","BK0114","BK0209"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662565340","title":"中邮证券：给予大参林买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2662565340","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662565340?lang=zh_cn&edition=full","pubTime":"2026-08-28 12:49","pubTimestamp":1787892590,"startTime":"0","endTime":"0","summary":"中邮证券有限责任公司盛丽华,龙永茂近期对大参林进行研究并发布了研究报告《利润增长亮眼，经营质量持续提升》，给予大参林买入评级。 分季度来看，Q2收入、利润均提速增长。最新盈利预测明细如下：该股最近90天内共有9家机构给出评级，买入评级7家，增持评级2家；过去90天内机构目标均价为22.88。本文数据来源于中邮证券有限责任公司，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800027782.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603233","161027"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662975702","title":"大参林（603233）2026年中报简析：营收净利润同比双双增长，盈利能力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2662975702","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662975702?lang=zh_cn&edition=full","pubTime":"2026-08-26 06:10","pubTimestamp":1787695855,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期大参林发布2026年中报。截至本报告期末，公司营业总收入139.91亿元，同比上升3.46%，归母净利润9.27亿元，同比上升16.1%。本报告期大参林盈利能力上升，毛利率同比增幅2.11%，净利率同比增幅12.97%。营业成本变动幅度为2.3%,原因:公司经营规模扩大，门店内生长及门店数量增加，同比营业成本增长。本文数据来源于大参林2026年中报，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082600009335.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603233"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662752912","title":"股市必读：大参林中报 - 第二季度单季净利润同比增长22.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662752912","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662752912?lang=zh_cn&edition=full","pubTime":"2026-08-26 04:39","pubTimestamp":1787690349,"startTime":"0","endTime":"0","summary":"截至2026年8月25日收盘，大参林报收于18.41元，上涨6.05%，换手率1.18%，成交量13.45万手，成交额2.45亿元。业绩披露要点财务报告2026年中报显示，上半年度主营收入139.91亿元，同比上升3.46%；归母净利润9.27亿元，同比上升16.1%；扣非净利润9.31亿元，同比上升18.05%；第二季度单季度主营收入70.18亿元，同比上升6.87%；单季度归母净利润4.16亿元，同比上升22.89%；单季度扣非净利润4.22亿元，同比上升26.22%；负债率65.05%，毛利率35.6%，投资收益-1078.98万元，财务费用6329.61万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082600008076.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603233"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662385957","title":"大参林(603233)6月30日股东户数2.56万户，较上期增加0.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662385957","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662385957?lang=zh_cn&edition=full","pubTime":"2026-08-25 17:37","pubTimestamp":1787650654,"startTime":"0","endTime":"0","summary":"证券之星消息，近日大参林披露，截至2026年6月30日公司股东户数为2.56万户，较3月31日增加214.0户，增幅为0.84%。在医药商业行业个股中，大参林股东户数低于行业平均水平，截至6月30日，医药商业行业平均股东户数为4.52万户。从股价来看，2026年3月31日至2026年6月30日，大参林区间跌幅为12.78%，在此期间股东户数增加214.0户，增幅为0.84%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082500036558.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0114","603233","BK0185","BK0209"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662782247","title":"8月25日大参林涨6.05%，兴全兴益债券A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2662782247","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662782247?lang=zh_cn&edition=full","pubTime":"2026-08-25 16:35","pubTimestamp":1787646941,"startTime":"0","endTime":"0","summary":"证券之星消息，8月25日大参林涨6.05%，收盘报18.41元，换手率1.18%，成交量13.45万手，成交额2.45亿元。根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共10家，其中持有数量最多的公募基金为兴证全球基金的兴全兴益债券A。兴全兴益债券A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082500033705.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0209","603233","BK0185","BK0114"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662783025","title":"国金证券：给予大参林买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2662783025","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662783025?lang=zh_cn&edition=full","pubTime":"2026-08-25 12:21","pubTimestamp":1787631702,"startTime":"0","endTime":"0","summary":"国金证券股份有限公司甘坛焕,王奔奔近期对大参林进行研究并发布了研究报告《Q2收入继续回暖，盈利表现优异》，给予大参林买入评级。关闭门店147家，闭店节奏已恢复此前常态化的动态调整。最新盈利预测明细如下：该股最近90天内共有4家机构给出评级，买入评级4家；过去90天内机构目标均价为24.0。本文数据来源于国金证券股份有限公司，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082500024118.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603233"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662383203","title":"图解大参林中报：第二季度单季净利润同比增长22.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662383203","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662383203?lang=zh_cn&edition=full","pubTime":"2026-08-25 01:57","pubTimestamp":1787594229,"startTime":"0","endTime":"0","summary":"证券之星消息，大参林2026年中报显示，上半年度公司主营收入139.91亿元，同比上升3.46%；归母净利润9.27亿元，同比上升16.1%；扣非净利润9.31亿元，同比上升18.05%；其中2026年第二季度，公司单季度主营收入70.18亿元，同比上升6.87%；单季度归母净利润4.16亿元，同比上升22.89%；单季度扣非净利润4.22亿元，同比上升26.22%；负债率65.05%，投资收益-1078.98万元，财务费用6329.61万元，毛利率35.6%。财报数据概要请见下图:本文数据来源于大参林2026年中报，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082500005099.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603233"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661272598","title":"大参林（603233）披露2026年半年度报告，8月24日股价下跌1.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2661272598","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661272598?lang=zh_cn&edition=full","pubTime":"2026-08-24 22:28","pubTimestamp":1787581704,"startTime":"0","endTime":"0","summary":"截至2026年8月24日收盘，大参林报收于17.36元，较前一交易日下跌1.7%，最新总市值为197.71亿元。该股当日开盘17.66元，最高17.75元，最低17.33元，成交额达1.06亿元，换手率为0.53%。近日，大参林医药集团股份有限公司披露2026年半年度报告。本报告期末总资产为25,854,778,046.31元，较上年度末减少2.39%；归属于上市公司股东的净资产为7,732,315,883.00元，较上年度末增长4.95%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082400037481.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0209","BK0185","BK0114","603233"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658920828","title":"大参林较去年高点跌65.59% 中泰证券等在高位喊买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2658920828","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658920828?lang=zh_cn&edition=full","pubTime":"2026-08-12 16:29","pubTimestamp":1786523350,"startTime":"0","endTime":"0","summary":"中国经济网北京8月12日讯 大参林 股价今日下跌，截至收盘报18.14元，跌幅3.82%。 2021年1月25日，大参林股价在盘中创下上市以来最高价106.50元。复权后大参林股价目前较历史高点跌幅达65.59%。 大参林于2021年6月3日公告称，每股派发现金红利0.8元(含税)，以资本公积金向全体股东每股转增0.2股，除权除息日2021年6月10日，股权登记日2021年6月9日。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20260812/32332806.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0114","BK0209","BK0185","BK0276","603233","600918"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657970076","title":"A股收评：沪指涨1.02%，超2800股上涨！CRO概念、AI硬件板块爆发","url":"https://stock-news.laohu8.com/highlight/detail?id=2657970076","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657970076?lang=zh_cn&edition=full","pubTime":"2026-08-07 15:03","pubTimestamp":1786086238,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0209","BK0188","BK0185","IE00B0JY6N72.USD","LU1226287529.USD","06821","603233","LU1580142542.USD","BK0114","BK0187","LU0072913022.USD","LU1655091616.SGD","LU1807302812.USD","LU0501845795.SGD","LU1328615791.USD","002821","LU0067412154.USD","000001","LU1993786604.SGD","LU0880133367.SGD","LU1781817850.SGD","BK0239","BK0132","BK0183","BK0201","BK0028","BK0012","BK0278"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654057548","title":"每周股票复盘：大参林（603233）2025年营收275.02亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2654057548","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654057548?lang=zh_cn&edition=full","pubTime":"2026-07-26 02:28","pubTimestamp":1785004093,"startTime":"0","endTime":"0","summary":"截至2026年7月24日收盘，大参林报收于18.4元，较上周的18.57元下跌0.92%。本周，大参林7月21日盘中最高价报19.49元。天健会计师事务所就大参林2025年年度报告问询函出具专项说明，涉及业务经营、商誉减值、货币资金及应付票据、其他往来款等事项。公司2025年实现营业收入275.02亿元，同比增长3.80%；期末应收账款12.60亿元，使用权资产及长期待摊费用余额下降。应付票据余额70.23亿元，货币资金65.09亿元，其中受限资金25.95亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072600000716.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603233"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653207335","title":"股市必读：新发布《天健会计师事务所（特殊普通合伙）关于大参林医药集团股份有限公司2025年年度报告问询函专项说明》","url":"https://stock-news.laohu8.com/highlight/detail?id=2653207335","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653207335?lang=zh_cn&edition=full","pubTime":"2026-07-22 02:20","pubTimestamp":1784658004,"startTime":"0","endTime":"0","summary":"天健会计师事务所关于大参林医药集团股份有限公司2025年年度报告问询函专项说明天健会计师事务所出具专项说明，确认大参林对2025年年报问询函所涉业务经营、商誉减值、货币资金及应付票据、其他往来款等事项的回复具备合理性。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072200002847.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1161","BK0114","603233","BK1515","159938","BK1574","BK0185","BK0209","09939"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653248667","title":"股市必读：新发布《天健会计师事务所（特殊普通合伙）关于大参林医药集团股份有限公司2025年年度报告问询函专项说明》","url":"https://stock-news.laohu8.com/highlight/detail?id=2653248667","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653248667?lang=zh_cn&edition=full","pubTime":"2026-07-21 02:16","pubTimestamp":1784571370,"startTime":"0","endTime":"0","summary":"天健会计师事务所关于大参林医药集团股份有限公司2025年年度报告问询函专项说明大参林对2025年年度报告的信息披露监管问询函作出回复，涵盖业务经营、商誉减值、货币资金及应付票据、其他往来款等事项。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072100001695.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0209","603233","09939","159938","BK1574","BK0114","BK0185","BK1515","BK1161"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1790446683624,"stockEarnings":[{"period":"1week","weight":-0.0415},{"period":"1month","weight":-0.0467},{"period":"3month","weight":0.1858},{"period":"6month","weight":0.031},{"period":"1year","weight":0.0716},{"period":"ytd","weight":0.0275}],"compareEarnings":[{"period":"1week","weight":0.0033},{"period":"1month","weight":-0.0003},{"period":"3month","weight":-0.0345},{"period":"6month","weight":-0.0065},{"period":"1year","weight":0.009},{"period":"ytd","weight":-0.0203}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"大参林医药集团股份有限公司","boardCode":"AI0052","boardName":"零售业","stockholders":"25624人(较上一季度增加0.84%)","perCapita":"44444股","listingDate":"2017-07-31","address":"广东省广州市荔湾区龙溪大道410号、410-1号","registeredCapital":"113885万元","survey":" 大参林医药集团股份有限公司的主营业务是中西成药、参茸滋补药材及中药饮片、保健品、医疗器械及其他商品的连锁零售业务。公司的主要产品是中西成药、中参药材、非药品。","listedPrice":24.72},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"大参林(603233)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供大参林(603233)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"大参林,603233,大参林股票,大参林股票老虎,大参林股票老虎国际,大参林行情,大参林股票行情,大参林股价,大参林股市,大参林股票价格,大参林股票交易,大参林股票购买,大参林股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"大参林(603233)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供大参林(603233)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}